Optional continuing education contact hours can be received if the survey is completed after watching the video.
Please view each individual video for updated instructions on how to receive this continuing education credit.
This program will evaluate various risk assessment methods and focus on risk reducing therapies for patients with an increased risk of breast cancer.
This program will discuss risk assessment, treatment and opportunities to increase access for genetic testing for patients at risk or diagnosed with prostate cancer.
This program will discuss hereditary renal tumor syndromes and highlight criteria for identifying patients at risk for hereditary renal cell carcinoma as well as discuss management for affected patients.
This program will highlight challenges in providing equitable care for sexual and gender minority patients and examine strategies to overcome these challenges within a clinical and research construct.
This program will outline current methods to identify patients at risk for hereditary colorectal cancer and discuss potential strategies to improve access for genetic testing and treatment for these patients.
This program will define and examine disparities in digital health literacy and provide solutions to improve education and communication for patients with cancer.
This webinar will highlight updates in cancer treatment associated with genomic and genetic testing and address challenges and benefits of improving clinical trial enrollment for patients with hereditary cancer.
This webinar will examine the American Society of Breast Surgeons (ASBrS) consensus guidelines on genetic testing for all patients with breast cancer and discuss its implications on local and systemic treatment recommendations.
This webinar will outline various disparities in hereditary cancer care and highlight tools, methods, and focused efforts to improve care delivery and reduce barriers in this patient population.
This webinar will summarize highlights from recent 2021 virtual meetings of the Society of Gynecologic Oncology and the National Consortium of Breast Centers, focusing on evolving strategies in hereditary breast and ovarian cancer.
This webinar will focus on evolving strategies in hereditary colorectal cancer. Program presentations will highlight novel therapies for risk reduction, additional genes and associated cancer risks as well as discuss the role of polygenic risk scores to identify and stratify colorectal cancer risks.
More webinars coming soon